Vernal Biosciences highlighted in article by Pharma’s Almanac!
Vernal’s mRNA platform manufacturing capabilities have gotten the attention of the mRNA community. Read Pharma’s Almanac’s expose on Vernal here: Platform Processes and End-to-End Capabilities Position Vernal…
Vernal’s growth plan going according to plan!
Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below to see what we’ve been up to….
Vernal Biosciences enters ‘mass hiring mode’ after raising $21 million in funding
Local NBC affiliate NBC5 came to visit Vernal Bioscience to discuss the eventual move to a new, larger facility in Essex and our plans to nearly quadruple…
Vermont-based biotech startup raises $21 million in funding for mRNA production.
Vernal produces high-purity mRNA to supply to companies that develop mRNA-based health treatments. Read the full story at VTDigger.
Colchester’s Vernal Biosciences Raises $20 Million to Expand
Vernal Biosciences has received $21 million from investors and is expanding to a new laboratory in Essex next year.
Burlington tech startup raises millions to accelerate manufacturing growth
Vernal Biosciences has raised $21 million to build a manufacturing facility in Essex that will scale up the business from supporting research to being involved in clinical…